Overview

Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and safety of different doses of ACT-129968 in adult patients with seasonal allergic rhinitis, due to mountain cedar pollen.
Phase:
Phase 2
Details
Lead Sponsor:
Actelion
Idorsia Pharmaceuticals Ltd.
Treatments:
Cetirizine